Advisors Preferred’s Core Laboratories CLB Stock Holding History

Advisors Preferred’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-112,071	Closed	-$2.5M	–	202
2023 Q2	$2.5M	Sell	112,071 -27,218	-20%	-$616K	0.62%	35
2023 Q1	$3.28M	Buy	139,289 +45,282	+48%	+$1.06M	1.12%	15
2022 Q4	$1.79M	Buy	94,007 +83,005	+754%	+$1.61M	0.76%	27
2022 Q3	$163K	Buy	+11,002	New	+$185K	0.08%	83

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisors Preferred's CLB Position: Q3 2023 in Review

Advisors Preferred sold out of Core Laboratories (CLB) in Q3 2023, closing a stake of 112,071 shares — an estimated $2.5M sold.

Advisors Preferred first reported a position in CLB in Q3 2022 and held it in 4 quarters. The position peaked at $3.28M in Q1 2023. 178 funds tracked by Wall St. Rank hold CLB as of Q3 2023.

Advisors Preferred reported no remaining Core Laboratories position as of Q3 2023 after selling out during the quarter.
Advisors Preferred sold 112,071 Core Laboratories shares in Q3 2023, an estimated $2.5M.
Advisors Preferred first reported a position in Core Laboratories in Q3 2022 and held it in 4 quarters.
Advisors Preferred's Core Laboratories position peaked at $3.28M in Q1 2023.
178 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2023.

Based on Advisors Preferred's 13F filing for Q3 2023, filed 7 Nov 2023.